Molina Healthcare (HAM:MHG) 5-Year EBITDA Growth Rate: 4.90% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:MHG Molina Healthcare Inc HAM:MHG
60 GF Score
Price €172.25
GF Value €338.63
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Molina Healthcare 5-Year EBITDA Growth Rate?

Molina Healthcare HAM:MHG +2.32% 60 5-Year EBITDA Growth Rate is 4.90% as of Jun. 2026. GuruFocus rates HAM:MHG with a GF Score™ of 60/100 and a GF Value™ of €338.63 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Molina Healthcare's EBITDA per Share for the three months ended in Jun. 2026 was €3.13.

During the past 12 months, Molina Healthcare's average EBITDA Per Share Growth Rate was -78.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Molina Healthcare was 53.70% per year. The lowest was -7.20% per year. And the median was 10.85% per year.


Molina Healthcare  (HAM:MHG) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Molina Healthcare 5-Year EBITDA Growth Rate Related Terms


HAM:MHG vs OSCR, ALHC, CLOV: 5-Year EBITDA Growth Rate Comparison

For the Healthcare Plans subindustry, Molina Healthcare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molina Healthcare 5-Year EBITDA Growth Rate vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Molina Healthcare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Molina Healthcare's 5-Year EBITDA Growth Rate falls into.


HAM:MHG
60GF Score
Molina Healthcare Inc HAM:MHG
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molina Healthcare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 4.90% mean?
Molina Healthcare (HAM:MHG) has a 5-Year EBITDA Growth Rate of 4.90% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Molina Healthcare and its competitors.
Is Molina Healthcare's 5-Year EBITDA Growth Rate too high?
Molina Healthcare's current 5-Year EBITDA Growth Rate is 4.90%. Overall, Molina Healthcare has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Molina Healthcare's 5-Year EBITDA Growth Rate compare to OSCR and ALHC?
Molina Healthcare's 5-Year EBITDA Growth Rate of 4.90% can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Plans company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Plans industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Molina Healthcare and its competitors. Molina Healthcare's current 5-Year EBITDA Growth Rate is 4.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molina Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Molina Healthcare (HAM:MHG) is currently considered Significantly Undervalued. The stock's GF Value™ is €338.63, compared to a current price of €172.25 — trading 49.1% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 4.90%. Molina Healthcare's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Molina Healthcare (HAM:MHG), the current 5-Year EBITDA Growth Rate is 4.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Molina Healthcare (HAM:MHG) Overvalued in 2026?

Based on GuruFocus' analysis, Molina Healthcare stock appears to be undervalued. The current stock price of €172.25 is trading 49.1% below its estimated GF Value™ of €338.63. GuruFocus considers Molina Healthcare to be Significantly Undervalued.

Key valuation signals for HAM:MHG:

  • 5-Year EBITDA Growth Rate: 4.90%
  • GF Value™: €338.63 vs. price of €172.25 (49.1% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the HAM:MHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Molina Healthcare Business Description

Address 200 Oceangate, Suite 100, Long Beach, CA, USA, 90802
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
60GF Score

Get the complete analysis for HAM:MHG

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€172.25
Price
€338.63
GF Value